Experimental therapies for Parkinson's disease: Why fake it?

Nature

Volumn 476, Issue 7359, 2011, Pages 142-144

  Katsnelson, Alla ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; GLUTAMATE DECARBOXYLASE; LEVODOPA; NEURTURIN; PLACEBO;

BRAIN; DISEASE TREATMENT; EXPERIMENTAL STUDY; MENTAL HEALTH; NERVOUS SYSTEM DISORDER; NEUROLOGY;

BIOTECHNOLOGY; BRAIN; BRAIN SURGERY; CELL THERAPY; CLINICAL TRIAL (TOPIC); DRUG EFFICACY; GAIT; GENE DELIVERY SYSTEM; GENE THERAPY; HUMAN; IMPLANT; IMPLANTATION; MOTOR PERFORMANCE; NERVE CELL; NEUROIMAGING; NEUROSCIENCE; NEUROSURGERY; NUCLEAR MAGNETIC RESONANCE IMAGING; PARKINSON DISEASE; PRIORITY JOURNAL; REVIEW; RISK REDUCTION; SHAM BRAIN SURGERY; SHAM PROCEDURE; SKULL; SPHERAMINE; STEREOTAXIC SURGERY; SYMPTOM; TREATMENT OUTCOME;

ADRENAL GLANDS; ADULT; CONTROLLED CLINICAL TRIALS AS TOPIC; FEMALE; HUMANS; MALE; MULTICENTER STUDIES AS TOPIC; PARKINSON DISEASE; PLACEBO EFFECT; PLACEBOS;

EID: 80051691847     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/476142a     Document Type: Review

References (15)

1. Stover, N. P. & Watts, R. L. Neurotherapeutics 5, 252-259 (2008).
2. Gross, R. E. et al. Lancet Neurol. 10, 509-519 (2011).
3. Madrazo, I. et al. N. Engl. J. Med. 316, 831-834 (1987).
4. Marks, W. J. et al. Lancet Neurol. 9, 1164-1172 (2010).
5. Freed, C. R. et al. N. Engl. J. Med. 344, 710-719 (2001).
6. Olanow, C. W. et al. Ann. Neurol. 54, 403-414 (2003).
7. Marks, W. J. et al. Lancet Neurol. 7, 400-408 (2008).
8. Gill, S. S. et al. Nature Med. 9, 589-595 (2003).
9. Lang, A. E. et al. Ann. Neurol. 59, 459-466 (2006).
10. Kim, S. Y. H. et al. Arch. Neurol. 62, 1357-1360 (2005).
11. de la Fuente-Fernández, R. et al. Science 293, 1164-1166 (2001).
12. McRae, C. et al. Arch. Gen. Psychiatry 61, 412-420 (2004).
13. Politis, M. et al. Sci. Transl. Med. 2, 38ra46 (2010).
14. Kaplitt, M. G. et al. Lancet 369, 2097-2105 (2007).
15. LeWitt, P. A. et al. Lancet Neurol. 10, 309-319 (2011).